Comparison of the Movement Disorder Society Parkinson's disease dementia criteria with neuropsychological testing

The objective of our study was to compare Movement Disorder Society Task Force criteria for diagnosis of Parkinson's disease dementia (PDD) with the gold standard of traditional neuropsychological testing. A short checklist (Level I) and a protocol of neuropsychological tests (Level II) have been proposed by a Movement Disorder Society Task Force but not fully validated in clinical practice. Ninety‐one Parkinson's disease (PD) subjects were categorized as having dementia or no dementia based on a battery of neuropsychological test results and clinical judgment. The isolated components needed for Level I and Level II diagnoses were then culled from the neuropsychological evaluations and independently used to designate PDD. Compared with traditional neuropsychological testing, the sensitivity and specificity of Level I criteria for PDD was 66.7% and 98.8%, and for Level II criteria 100% and 92.7%, respectively. Using Level II criteria, 6 additional subjects were diagnosed with PDD that were classified as having no dementia when full neuropsychological data were used for the diagnosis. These 6 subjects had more education years and were less impaired on cognitive tests. The Movement Disorder Society's Level II criteria more frequently classify subjects with PDD than does traditional neuropsychological testing. Whereas Level II criteria may overclassify subjects as having PDD, they are very accurate in ruling out dementia. Movement Disorder Society's criteria are practical and timesaving, although full neuropsychological testing may still be needed. © 2014 International Parkinson and Movement Disorder Society

[1]  J. Godet,et al.  The Movement Disorders Society criteria for the diagnosis of Parkinson’s disease dementia: their usefulness and limitations in elderly patients , 2013, Journal of Neurology.

[2]  R. Barker,et al.  Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines , 2012, Movement disorders : official journal of the Movement Disorder Society.

[3]  B. Dubois,et al.  Clinical validation of movement disorder society–recommended diagnostic criteria for Parkinson's disease with dementia , 2012, Movement disorders : official journal of the Movement Disorder Society.

[4]  D. Aarsland,et al.  Dementia associated with Parkinson's disease: applying the Movement Disorder Society Task Force criteria. , 2011, Parkinsonism & related disorders.

[5]  C. Adler,et al.  MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD‐MCI , 2011, Movement disorders : official journal of the Movement Disorder Society.

[6]  S. Bernardi,et al.  A simplified algorithm may lead to overestimate dementia in PD. A clinical and epidemiological study using criteria for PD-D proposed by the Movement Disorders Task Force , 2011, Journal of neural transmission.

[7]  K. Dujardin,et al.  Parkinson's disease dementia can be easily detected in routine clinical practice , 2010, Movement disorders : official journal of the Movement Disorder Society.

[8]  L. Forsgren,et al.  Cognitive function in early Parkinson’s disease: a population‐based study , 2009, European journal of neurology.

[9]  Murat Emre,et al.  Parkinson's disease dementia: Definitions, guidelines, and research perspectives in diagnosis , 2008, Annals of neurology.

[10]  E. Tolosa,et al.  Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force , 2007, Movement disorders : official journal of the Movement Disorder Society.

[11]  E. Tolosa,et al.  Clinical diagnostic criteria for dementia associated with Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[12]  M. Hely,et al.  Sydney multicenter study of Parkinson's disease: Non‐L‐dopa–responsive problems dominate at 15 years , 2005, Movement disorders : official journal of the Movement Disorder Society.

[13]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[14]  D. Royall,et al.  The FAB: A frontal assessment battery at bedside , 2001, Neurology.

[15]  Yaakov Stern,et al.  Dementia in Parkinson's disease , 1994, Neurology.

[16]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[17]  M. Åsberg,et al.  A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.

[18]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[19]  M. Hamilton A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[20]  R. Reitan Validity of the Trail Making Test as an Indicator of Organic Brain Damage , 1958 .

[21]  J. Ridley Studies of Interference in Serial Verbal Reactions , 2001 .

[22]  H. Mayberg,et al.  Reliability, validity, and clinical correlates of apathy in Parkinson's disease. , 1992, The Journal of neuropsychiatry and clinical neurosciences.

[23]  J. Stroop Studies of interference in serial verbal reactions. , 1992 .